吡昔替尼结构式
|
常用名 | 吡昔替尼 | 英文名 | Pexidartinib |
|---|---|---|---|---|
| CAS号 | 1029044-16-3 | 分子量 | 417.815 | |
| 密度 | 1.5±0.1 g/cm3 | 沸点 | 580.0±50.0 °C at 760 mmHg | |
| 分子式 | C20H15ClF3N5 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | 304.6±30.1 °C |
吡昔替尼用途Pexidartinib (PLX-3397)是多靶点受体酪氨酸激酶抑制剂, 抑制 CSF1R,c-Kit,FLT3 的 IC50 分别为13 nM,27 nM,11 nM。 |
| 中文名 | 吡昔替尼 |
|---|---|
| 英文名 | Pexidartinib |
| 英文别名 | 更多 |
| 描述 | Pexidartinib (PLX-3397)是多靶点受体酪氨酸激酶抑制剂, 抑制 CSF1R,c-Kit,FLT3 的 IC50 分别为13 nM,27 nM,11 nM。 |
|---|---|
| 相关类别 | |
| 靶点实验 |
IC50: 28 nM (c-Fms), 16 nM (c-Kit) |
| 体内研究 | Pexidartinib是治疗癌症的有效药物,用于III期TGCT临床试验[1]。 |
| 参考文献 |
| 密度 | 1.5±0.1 g/cm3 |
|---|---|
| 沸点 | 580.0±50.0 °C at 760 mmHg |
| 分子式 | C20H15ClF3N5 |
| 分子量 | 417.815 |
| 闪点 | 304.6±30.1 °C |
| 精确质量 | 417.096802 |
| PSA | 66.49000 |
| LogP | 4.77 |
| InChIKey | JGWRKYUXBBNENE-UHFFFAOYSA-N |
| SMILES | FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1 |
| 外观性状 | 粉末 |
| 蒸汽压 | 0.0±1.6 mmHg at 25°C |
| 折射率 | 1.662 |
| 储存条件 | -20℃ |
| 危害码 (欧洲) | N |
|---|
|
实验名称:Primary qHTS assay for inhibitors of alpha-synuclein gene (SNCA) expression
来源:NCGC
External Id:SNCA-p-activity-luciferase
|
|
实验名称:Human KIT proto-oncogene receptor tyrosine kinase (Type III RTKs: PDGFR, CSFR, Kit, F...
来源:IUPHAR-DB
靶标:KIT proto-oncogene receptor tyrosine kinase (Type III RTKs: PDGFR, CSFR, Kit, FLT3 receptor family) [Homo sapiens]
External Id:1805_Human
|
|
实验名称:Human fms related tyrosine kinase 1 (Type IV RTKs: VEGF (vascular endothelial growth ...
来源:IUPHAR-DB
靶标:fms related tyrosine kinase 1 (Type IV RTKs: VEGF (vascular endothelial growth factor) receptor family) [Homo sapiens]
External Id:1812_Human
|
|
实验名称:Antialzheimer activity in 5XFAD mouse assessed as average plaque volume in somatosens...
来源:ChEMBL
靶标:Mus musculus
External Id:CHEMBL5653442
|
|
实验名称:Human neurotrophic receptor tyrosine kinase 3 (Type VII RTKs: Neurotrophin receptor/T...
来源:IUPHAR-DB
靶标:neurotrophic receptor tyrosine kinase 3 (Type VII RTKs: Neurotrophin receptor/Trk family) [Homo sapiens]
External Id:1819_Human
|
|
实验名称:Cytotoxicity activity against human HepG2 cells assessed by CellTiter-Glo luminescent...
来源:ChEMBL
靶标:HepG2
External Id:CHEMBL5303715
|
|
实验名称:Effect of Compound I on CSF1R Kinase Activity from US Patent US20230382871: "CSF1R KI...
来源:BindingDB
靶标:N/A
External Id:BindingDB_11657_1
|
|
实验名称:Primary qHTS for inhibitors of NSP2Pro chikungunya virus (CHIKV)
来源:NCGC
External Id:APP-Toga-CHIKV-nsp2-p
|
|
实验名称:Thermal Shift Assay. Domain: start/stop: E122-S403
来源:ChEMBL
靶标:Aurora kinase A
External Id:CHEMBL5067447
|
|
实验名称:Incucyte cell viability with human fibroblast
来源:ChEMBL
靶标:Fibroblast
External Id:CHEMBL4725213
|
| PLX3397 |
| 5-[(5-Chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl]-N-{[6-(trifluoromethyl)-3-pyridinyl]methyl}-2-pyridinamine |
| N-[5-[(5-Chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl]-2-pyridinyl]-6-(trifluoromethyl)-3-pyridinemethanamine |
| PLX-3397 |
| pexidartinib |